LLNI Funded Publications
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.
Author:Boullosa LF
Other Authors: Savaliya P, Bonney S, Orchard L, Wickenden H, Lee C, Smits E, Banham AH, Mills KI, Orchard K, Guinn BA,
Last Updated:25/07/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.18632/oncotarget.23380
Journal:Oncotarget
Volume:9
Issue:3
Pages:3853-3866
Date: January 2018
